1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Growing Patient awareness
4.1.2 Increasing SPECT and PET applications
4.1.3 Development of better instruments
4.14 Rising incidences of Cancer and Cardiac disorders
4.2 Restraints
4.2.1 Reimbursement Problems
4.2.2 Strict Regulatory Issues
4.3 Opportunities
4.3.1 Cyclotron based production
4.3.2 Increasing neurological applications
4.3.3 Potential Radioisotopes in pipeline
4.4.4 Increasing Imaging Technologies
4.4 Challenges
4.4.1 Shutdown of Nuclear Reactors to Impact Production of Radioisotopes
5. Europe Nuclear Medicine Radioisotopes Market – By Type of Radioisotopes
5.1 Iridium-192
5.2 Palladium-103
5.3 Iodine-125
5.4 Cesium-131
5.5 Thorium-227 (Th-227)
5.6 Radium-224 (Ra-224)
5.7 Astatine-211 (At-211)
5.8 Lead-212 (Pb-212)/Bismuth-212 (Bi-212)
5.9 Actinium-225 (Ac-225)
5.10 Radium-223 (Ra-223) & Alpharadin
5.11 Lutetium-177 (Lu-177)
5.12 Rhenium-186 (Re-186)
5.13 Samarium-153 (Sm-153)
5.14 Yttrium-90 (Y-90)
5.15 Iodine-131 (I-131)
5.16 Rubidium-82 (Rb-82)
5.17 Fluorine-18
5.18 Iodine (I-123)
5.19 Thallium-201 (Tl-201)
5.20 Technetium-99m (Tc-99m)
5.21 Others
6. Europe Nuclear Medicine Radioisotopes Market-By Applications
6.1 Neurology
6.2 Thyroid
6.3 Lymphoma
6.4 Cardiology
6.5 Oncology
6.6 Others
7. Europe Nuclear Medicine Radioisotopes Market - By Country
7.1. Introduction
7.2. UK
7.3. Germany
7.4. France
7.5 Rest of Europe
8. Company Profiles
8.1 Medix Inc.
8.2 IBA Molecular Imaging
8.3 Lantheus Medical Imaging Inc.
8.4 Bayer Healthcare
8.5 Naviscan Inc.
8.6 Bracco Imaging S.P.A
8.7 Positron Corporation
8.8 Segami Corporation
8.9 Hologic Inc.
8.10 GE Healthcare
8.11 Cardinal Health, Inc.
8.12 Mallinckrodt PLC
8.13 Eczacibasi-Monrol Nuclear Products
8.14 Nordion, Inc.
8.15 Advanced Accelerator Applications S.A.
9. Europe Nuclear Medicine Radioisotopes Market - Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
